Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 12:38 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2641–2664 of 3,983 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Pathophysiology Clear all

Conditions: Depression
Interventions: Memantine HCL; Drug
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: Not listed
Enrollment: 112 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2005
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Hip Fractures, Cognitive Impairment
Interventions: HipERS; Behavioral
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 65 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Insomnia, Insomnia Chronic, Insomnia, Primary, Sleep Disturbance, Sleep Disorder, Cardiovascular Diseases, Heart Diseases, Coronary Artery Disease, Stroke, Autonomic Dysfunction, Systemic Inflammatory Response, Metabolic Disease
Interventions: Sleep Healthy Using The Internet (SHUTi), Telephonic CBT-I, Face-to-Face CBT-I, Active Control: Sleep Education/Hygiene, Symptom Monitoring, and Usual Primary Care; Behavioral · Other
Lead sponsor: Indiana University; Other
Eligibility: 40 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Mild Cognitive Impairment, Alzheimer's Disease
Interventions: Transcranial direct current stimulation (tDCS); Device
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 50 Years to 88 Years
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2017
U.S. locations: 2
States / cities: Decatur, Georgia • Ann Arbor, Michigan

Conditions: Sexual Function
Interventions: Perineorrhaphy; Procedure
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 19 Years to 105 Years · Female only
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2017
U.S. locations: 2
States / cities: Birmingham, Alabama • Winston-Salem, North Carolina

Conditions: Cognitive Impairment, Alzheimer Blood Biomarkers, Alzheimer Disease (AD), Mild Cognitive Impairment (MCI)
Interventions: Multimodal Lifestyle Intervention; Behavioral
Lead sponsor: HudsonAlpha Institute for Biotechnology; Other
Eligibility: 65 Years to 75 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Huntsville, Alabama

Conditions: Female Sexual Dysfunction, Spinal Cord Injuries
Interventions: Transcutaneous electrical nerve stimulation - Tibial Nerve, Transcutaneous electrical nerve stimulation - Genital Nerve; Device
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older · Female only
Enrollment: 9 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Cognitive Impairment
Interventions: Sharing Healthcare Wishes in Primary Care (SHARE), Minimally Enhanced Usual Care; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 80 Years and older
Enrollment: 273 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 9
States / cities: Baltimore, Maryland • Dundalk, Maryland • Mitchellville, Maryland + 3 more

Conditions: Amyotrophic Lateral Sclerosis (ALS)
Interventions: Nuedexta, Matching Placebo; Drug
Lead sponsor: Center for Neurologic Study, La Jolla, California,; Other
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 7
States / cities: San Francisco, California • Washington D.C., District of Columbia • Grand Rapids, Michigan + 4 more

Conditions: Parkinson Disease, Cognitive Dysfunction, Memory Disorders
Interventions: HOme-Based Self-management and COgnitive Training CHanges lives (HOBSCOTCH); Behavioral
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 30 Years to 75 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: Cognitive Impairments, RRSO
Interventions: lisdexamfetamine, Placebo; Drug
Lead sponsor: University of Pennsylvania; Other
Eligibility: 30 Years to 60 Years · Female only
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Chagas Disease
Interventions: LXE408, Placebo, Benznidazole; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2031
U.S. locations: 4
States / cities: Sylmar, California • Gainesville, Florida • Boston, Massachusetts + 1 more

Conditions: Hypertension, Obesity, Type 2 Diabetes, Insulin Resistance
Interventions: EGCG; Drug
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 21 Years to 65 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2015
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Pelvic Organ Prolapse
Interventions: Exair Prolapse Repair System, Total Native Tissue Repair; Device · Procedure
Lead sponsor: Coloplast A/S; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 79 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 13
States / cities: Savannah, Georgia • Fort Wayne, Indiana • Dearborn, Michigan + 9 more

Conditions: Postural Balance
Interventions: Neuromuscular electrical stimulation (NMES), Multi-Modality Balance Intervention (MMBI); Other
Lead sponsor: Baltimore VA Medical Center; Federal
Eligibility: 60 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Dementia, Cognition, End-stage Renal Disease
Interventions: Not listed
Lead sponsor: University of Chicago; Other
Eligibility: 60 Years and older
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Lung Transplant; Complications
Interventions: Extracorporeal Membrane Oxygenation, Cardiopulmonary Bypass; Device
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Mild Cognitive Impairment, Dementia
Interventions: TabCAT Brain Health Assessment Clinical Pathway; Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 180,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Pasadena, California

Conditions: Memory Disorders, Mild Cognitive Impairment, Dementia, Social Isolation, Caregiver Burden
Interventions: Social Reminder System; Behavioral
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Autosomal-dominant Hyper-IgE Syndrome
Interventions: NDV-3A; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 55 Years
Enrollment: 3 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Erectile Dysfunction, Sexual Dysfunction, Physiological
Interventions: Levitra (Vardenafil, BAY38-9456), Placebo; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years to 64 Years · Male only
Enrollment: 628 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2007
U.S. locations: 11
States / cities: Laguna Hills, California • Jeffersonville, Indiana • Des Moines, Iowa + 8 more

Conditions: Hepatic Complications, Malignant Neoplasm
Interventions: bortezomib, pharmacological study; Drug · Other
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2004
U.S. locations: 3
States / cities: Duarte, California • Baltimore, Maryland • Detroit, Michigan

Conditions: Metabolic Dysfunction-assocated Steatohepatitis/ Nonalcoholic Fatty Liver Disease
Interventions: TVB-2640, Placebo; Drug · Other
Lead sponsor: Sagimet Biosciences Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 168 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 103
States / cities: Huntsville, Alabama • Madison, Alabama • Sun City, Arizona + 80 more

Conditions: Segmental and Somatic Dysfunction of Other Regions (M99.09)
Interventions: OMT; Other
Lead sponsor: New York Institute of Technology; Other
Eligibility: 18 Years to 65 Years
Enrollment: 29 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Jonesboro, Arkansas

Search by objective public record fields.

Clinical Trial of Memantine for Major Depression

Hip Fracture Exercise and Rehabilitation Post Hip Fracture Study

SHADES Mechanistic Trial

Enhancing Spatial Navigation Using Non-Invasive Brain Stimulation

Evaluating Sexual Function After Vaginal Repair With Perineorrhaphy

Impact of a Multimodal Lifestyle Intervention on Dementia Risk Factors and Attitude Related to Dementia Risk: A Logistical Pilot Study

Effect of Peripheral Neuromodulation on Vaginal Blood Flow

SHARE: Sharing Healthcare Wishes in Primary Care

Clinical Trial Nuedexta in Subjects With ALS

HOme-Based Self-management and COgnitive Training CHanges Lives (HOBSCOTCH)-Parkinson's Disease (HOBSCOTCH-Parkinson's)

LDX for the Treatment of Cognitive Functioning Issues in Women Post-Oophorectomy

A Study of Efficacy, Safety, Tolerability of LXE408 in Participants With Chronic Chagas Disease.

Effect of EGCG on the Body's Response to Insulin

Exair® Versus Native Tissue Repair for Prolapse

NMES to Improve Hip Abductor Strength and Balance

Cognitive and Functional Status and Dialysis Outcomes in Older Hemodialysis Patients

Bypass vs. Ecmo in Lung Transplantation (BELT)

TabCAT Brain Health Assessment in Primary Care

A Mobile Informatics Solution to Assist Caregivers in Care Coordination and Monitoring Social Engagement

Safety, Tolerability, and Immunogenicity of One Dose of NDV 3A Vaccine in People With STAT3-Mutated Hyper-IgE Syndrome

Study to Compare the Tolerability and Efficacy of Once Daily Vardenafil vs Vardenafil PRN vs Placebo in Men Immediately After Nerve-sparing Prostatectomy for Improving ED

Bortezomib in Treating Patients With Advanced Cancer and Liver Dysfunction

Study of TVB-2640 in Subjects With Nonalcoholic Steatohepatitis (NASH)

Effects of Osteopathic Manipulative Treatment of Fascial Restrictions on Body Awareness, Mood, and Proprioception